Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 123
| शीर्षक | मुख्य जाँचकर्ता | शुरुवाती साल | निधीयन एजेंसी | ध्यानाकर्षण क्षेत्र |
|---|---|---|---|---|
| Identification and development of potential antiviral drug molecules against SARS-CoV-2 | Prof Shailly Tomar, Indian Institute of Technology (IIT) Roorkee | 2020 | Drug repurposing for COVID-19 | |
| Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells | Dr Mirza S Baig, Associate Professor, Indian Institute of Technology (IIT) Indore | 2020 | Drug repurposing for COVID-19 | |
| Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy | Dr Sanjeeva Srivastava, Professor, Indian Institute of Technology (IIT), Mumbai | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy | Prof Sanjeeva Srivastava, Assistant Professor, Indian Institute of Technology (IIT) Bombay, Dr Om Shrivastav, Director, , Jaslok Hospital, Mumbai, Dr Jayanthi S. Shastri, Professor & Head, T N Medical College & Nair Hospital, Dr Mala Vinod Kaneria, Jaslok Hospital, Mumbai | 2020 | Drug repurposing for COVID-19 | |
| Identification of novel antiviral targets for COVID-19 | Prof G Subba Rao, Associate Professor, Indian Institute of Science (IISc), Bengaluru | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| Identifying Possible Potent Inhibitors against COVID-19 via Computational Drug Repurposing Study | Dr Parimal Kar, Assistant Professor, Indian Institute of Technology (IIT) Indore | 2020 | Drug repurposing for COVID-19 | |
| Identifying potential drug targets in the structural proteins of SARS-Cov-2 | Dr Thenmalarchelvi, Associate Professor, Indian Institute of Technology (IIT) Hyderabad | 2020 | Drug repurposing for COVID-19 | |
| In silico discovery and biological evaluation of potential drug molecules to improve the treatment of Bedaquiline and Delamanid resistance in Mycobacterium tuberculosis. | Dr. Shalini Saxena, University of Hyderabad, Telangana (500046) | 2024 | Department of Science and Technology (DST) | Drug Discovery and Microbiology |
| In silico screening for repurposing known drugs for SARS-CoV-2 using AI and molecular simulations | Prof. Jayant Kumar Singh, Professor, Indian Institute of Technology (IIT), Kanpur | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |
| In-situ Gel for Rapid Capture and Inactivation of 2019-nCoV | Prof Kiran Kondabagil, Assistant Professor, Prof Rinti Banerjee, Prof Ashutosh Kumar, Associate Professor, Prof Shamik Sen, Associate Professor, Indian Institute of Technology (IIT) Bombay | 2020 | Drug repurposing for COVID-19 |